The government is set to review its policy on 'co-payment' for medicines, which could enable patients to contribute towards the …
The first European television adverts to promote a ‘cosmaceutical’ product have been broadcast in the UK.They feature Restylane, which is …
Clinical trial software specialist ClinPhone is at the centre of a bidding war between two of the world's largest clinical …
Medical education has always been an important part of the mix within pharmaceutical marketing. The planning and development of high …
'Conservative' pharmaceutical industry slow to take advantage of online marketing opportunitiesWhile the internet has altered the landscape in the retail …
The government has sent a warning to failing NHS trusts that their management will be turned over to the private …
A new study of Merck Sharp & Dohme's Januvia showed it lowered the risk of hypoglycaemia, compared to an older …
The King's Fund has called for greater effort to be made by government to help people improve their health. The …
European regulators have given GlaxoSmithKline's Tyverb conditional approval, clearing it for launch but asking for more clinical data. Tyverb (lapatinib) …
Japanese company Daiichi Sankyo is set to take over Ranbaxy, the largest manufacturer of generic drugs in India. Ranbaxy will …
The health secretary has hit back in the fight over polyclinics saying the BMA is not being honest with its …
Pharmacovigilance solutions: essential for the future of healthcareAlthough many newer pharmacovigilance solutions are still in the nascent stages, and despite …
A government strategy to transform primary care in England has been dealt a blow by a respected think tank, which …
Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …
A new study has confirmed that Roche's Avastin significantly extends time without disease progression for women with metastatic breast cancer. …
Drug distribution restricted as manufacturers attempt to guard supply chain Ideally, drug supply should be a simple and transparent chain …
Sanofi-Aventis is taking legal action to prevent the launch of a generic competitor to its blockbuster Plavix in Germany. At …
With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …